Indonesia
Tuberculosis profile
| High TB burden | High HIV burden | High MDR-TB burden |
Population  2012 247 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 67 (30–120) 27 (12–48)
Mortality (HIV+TB only) 2.1 (1.8–3) 0.86 (0.74–1.2)
Prevalence  (includes HIV+TB) 730 (350–1 200) 297 (144–506)
Incidence  (includes HIV+TB) 460 (380–540) 185 (153–220)
Incidence (HIV+TB only) 7.5 (5.6–9.7) 3.1 (2.3–3.9)
Case detection, all forms (%) 72 (61–87)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 202 319 (63) Relapse 5 942 (70)
Smear-negative 104 866 (32) Treatment after failure 467 (5)
Smear-unknown / not done     Treatment after default 954 (11)
Extrapulmonary 15 697 (5) Other 1 179 (14)
Other          
Total new 322 882   Total retreatment 8 542  
           
Other (history unknown)          
Total new and relapse 328 824   Total cases notified 331 424  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.5 1.3 0.9
Age < 15 1 703 22 956 2 684
Laboratories 2012
Smear (per 100 000 population) 2.3
Culture (per 5 million population) 0.9
Drug susceptibility testing (per 5 million population) 0.1
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 90   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 85  
Retreatment 71  
TB/HIV 2012 Number (%)
TB patients with known HIV status 2 676 (<1)
HIV-positive TB patients 754 (28)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 133 (18)
HIV-positive TB patients on antiretroviral therapy (ART) 221 (29)
HIV-positive people screened for TB 22 677  
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.9 (1.4–2.5) 12 (8.1–17)
MDR-TB cases among notified pulmonary
TB cases
5 800 (4 300–7 700) 1 000 (690–1 500)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 2 (<1%) 821 (10%) 824
Laboratory-confirmed MDR-TB cases 2 425 428
Patients started on MDR-TB treatment     426
Financing TB control 2013
National TB programme budget (US$ millions) 119
% Funded domestically 14%
% Funded internationally 35%
% Unfunded 51%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-16 Data: www.who.int/tb/data